ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Forms Office of Combination Products;

January 10, 2003

In Brief: John Minton Dies Forom Auto Accident Injuries; FDA Rules Against Generic Megastrol Acetate

January 11, 1991

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

June 3, 1983

“Soft Soap” Comprehensive Center Review Still Stung Some; NSAB Left With Perplexing Situations

May 26, 1978

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Congressman Obey Attacks NCI for Not Supporting Basic Research

January 23, 1976